CovidChloroV1, Main, Exploration, bibRecord, 000102

The Potentially Recommended Pharmacotherapy for COVID-19.

Identifieur interne : 000102 ( Main/Exploration ); précédent : 000101; suivant : 000103

The Potentially Recommended Pharmacotherapy for COVID-19.

Auteurs : Saeed Ur Rashid Nazir ; Taha Nazir ; Misbah Sultana ; Rahat Shamim ; Humayun Riaz ; Safia Sultana Munir ; Ruqaiya Rasheed Kayani ; Saba Manzoor ; Azharul Islam

Source :

Alternative therapies in health and medicine [ 1078-6791 ] ; 2021.

RBID : pubmed:33373324

Descripteurs français

KwdFr :
- Antiviraux (usage thérapeutique), Chine (MeSH), Humains (MeSH), Pakistan (MeSH), Pandémies (MeSH).
MESH :
- usage thérapeutique : Antiviraux.
- Chine, Humains, Pakistan, Pandémies.
Wicri :
- geographic : République populaire de Chine, Pakistan.

English descriptors

KwdEn :
- Antiviral Agents (therapeutic use), COVID-19 (MeSH), China (MeSH), Humans (MeSH), Pakistan (MeSH), Pandemics (MeSH), SARS-CoV-2 (MeSH).
MESH :
- chemical , therapeutic use : Antiviral Agents.
- geographic : China, Pakistan.
- COVID-19, Humans, Pandemics, SARS-CoV-2.

Abstract

Context

A completely unique coronavirus (2019-nCoV), formally referred to as severe acute respiratory syndrome (SARS-CoV-2), appeared in China. SARS-CoV-2 is an etiological mediator of coronavirus 2 (COVID-19), characterized by pneumonic contagion in human beings. In spite of forceful suppression, this virus has spread worldwide. No specific drugs have been approved by the FDA for treating COVID-19 patients.

Objective

The study intended to examine the data from studies on clinical management of COVID-19.

Design

The research team performed a literature review, searching relevant literature databases. The sources of data included bioRxiv, medRxiv, Google Scholar, Embase, PsychINFO, WanFang Data, and PubMed. The search terms were treatment of the novel coronavirus, management of nCoV-19, chloroquine, and hydroxychloroquine.

Setting

The study took place in the main library of the University of Sargodha in Sargodha, Pakistan.

Results

The study identified 42 unique studies that had reported and confirmed over 1500 cases of nCoV-19 by April 21, 2020. The studies found that clinical management, for patients who presented with symptoms, included supportive care and control measures that comprised mechanical ventilator support and supplementary oxygen.

Conclusions

There have been intensive attempts to explore drug therapy for the prophylaxis and treatment of SARS-CoV-2 infection during this COVID-19 pandemic. Several drugs have been identified which including remdesivir, two antimalarials (chloroquine and hydroxychloroquine) and immunosuppressive agents. The effects of most drug interventions are currently highly uncertain and several drugs and vaccines are under trail for the effective treatment of COVID-19 virus, until an effective treatment will discover social distancing and physical hygiene should be practiced strictly.

PubMed: 33373324

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000585
to stream Main, to step Curation: 000585

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Potentially Recommended Pharmacotherapy for COVID-19.</title>
<author><name sortKey="Nazir, Saeed Ur Rashid" sort="Nazir, Saeed Ur Rashid" uniqKey="Nazir S" first="Saeed Ur Rashid" last="Nazir">Saeed Ur Rashid Nazir</name>
</author>
<author><name sortKey="Nazir, Taha" sort="Nazir, Taha" uniqKey="Nazir T" first="Taha" last="Nazir">Taha Nazir</name>
</author>
<author><name sortKey="Sultana, Misbah" sort="Sultana, Misbah" uniqKey="Sultana M" first="Misbah" last="Sultana">Misbah Sultana</name>
</author>
<author><name sortKey="Shamim, Rahat" sort="Shamim, Rahat" uniqKey="Shamim R" first="Rahat" last="Shamim">Rahat Shamim</name>
</author>
<author><name sortKey="Riaz, Humayun" sort="Riaz, Humayun" uniqKey="Riaz H" first="Humayun" last="Riaz">Humayun Riaz</name>
</author>
<author><name sortKey="Sultana Munir, Safia" sort="Sultana Munir, Safia" uniqKey="Sultana Munir S" first="Safia" last="Sultana Munir">Safia Sultana Munir</name>
</author>
<author><name sortKey="Kayani, Ruqaiya Rasheed" sort="Kayani, Ruqaiya Rasheed" uniqKey="Kayani R" first="Ruqaiya Rasheed" last="Kayani">Ruqaiya Rasheed Kayani</name>
</author>
<author><name sortKey="Manzoor, Saba" sort="Manzoor, Saba" uniqKey="Manzoor S" first="Saba" last="Manzoor">Saba Manzoor</name>
</author>
<author><name sortKey="Islam, Azharul" sort="Islam, Azharul" uniqKey="Islam A" first="Azharul" last="Islam">Azharul Islam</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33373324</idno>
<idno type="pmid">33373324</idno>
<idno type="wicri:Area/Main/Corpus">000585</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000585</idno>
<idno type="wicri:Area/Main/Curation">000585</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000585</idno>
<idno type="wicri:Area/Main/Exploration">000585</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The Potentially Recommended Pharmacotherapy for COVID-19.</title>
<author><name sortKey="Nazir, Saeed Ur Rashid" sort="Nazir, Saeed Ur Rashid" uniqKey="Nazir S" first="Saeed Ur Rashid" last="Nazir">Saeed Ur Rashid Nazir</name>
</author>
<author><name sortKey="Nazir, Taha" sort="Nazir, Taha" uniqKey="Nazir T" first="Taha" last="Nazir">Taha Nazir</name>
</author>
<author><name sortKey="Sultana, Misbah" sort="Sultana, Misbah" uniqKey="Sultana M" first="Misbah" last="Sultana">Misbah Sultana</name>
</author>
<author><name sortKey="Shamim, Rahat" sort="Shamim, Rahat" uniqKey="Shamim R" first="Rahat" last="Shamim">Rahat Shamim</name>
</author>
<author><name sortKey="Riaz, Humayun" sort="Riaz, Humayun" uniqKey="Riaz H" first="Humayun" last="Riaz">Humayun Riaz</name>
</author>
<author><name sortKey="Sultana Munir, Safia" sort="Sultana Munir, Safia" uniqKey="Sultana Munir S" first="Safia" last="Sultana Munir">Safia Sultana Munir</name>
</author>
<author><name sortKey="Kayani, Ruqaiya Rasheed" sort="Kayani, Ruqaiya Rasheed" uniqKey="Kayani R" first="Ruqaiya Rasheed" last="Kayani">Ruqaiya Rasheed Kayani</name>
</author>
<author><name sortKey="Manzoor, Saba" sort="Manzoor, Saba" uniqKey="Manzoor S" first="Saba" last="Manzoor">Saba Manzoor</name>
</author>
<author><name sortKey="Islam, Azharul" sort="Islam, Azharul" uniqKey="Islam A" first="Azharul" last="Islam">Azharul Islam</name>
</author>
</analytic>
<series><title level="j">Alternative therapies in health and medicine</title>
<idno type="ISSN">1078-6791</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term>
<term>COVID-19 (MeSH)</term>
<term>China (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Pakistan (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (usage thérapeutique)</term>
<term>Chine (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Pakistan (MeSH)</term>
<term>Pandémies (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term>
<term>Pakistan</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Humans</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Chine</term>
<term>Humains</term>
<term>Pakistan</term>
<term>Pandémies</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term>
<term>Pakistan</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>Context</b>
</p>
<p>A completely unique coronavirus (2019-nCoV), formally referred to as severe acute respiratory syndrome (SARS-CoV-2), appeared in China. SARS-CoV-2 is an etiological mediator of coronavirus 2 (COVID-19), characterized by pneumonic contagion in human beings. In spite of forceful suppression, this virus has spread worldwide. No specific drugs have been approved by the FDA for treating COVID-19 patients.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Objective</b>
</p>
<p>The study intended to examine the data from studies on clinical management of COVID-19.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Design</b>
</p>
<p>The research team performed a literature review, searching relevant literature databases. The sources of data included bioRxiv, medRxiv, Google Scholar, Embase, PsychINFO, WanFang Data, and PubMed. The search terms were treatment of the novel coronavirus, management of nCoV-19, chloroquine, and hydroxychloroquine.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Setting</b>
</p>
<p>The study took place in the main library of the University of Sargodha in Sargodha, Pakistan.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Results</b>
</p>
<p>The study identified 42 unique studies that had reported and confirmed over 1500 cases of nCoV-19 by April 21, 2020. The studies found that clinical management, for patients who presented with symptoms, included supportive care and control measures that comprised mechanical ventilator support and supplementary oxygen.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Conclusions</b>
</p>
<p>There have been intensive attempts to explore drug therapy for the prophylaxis and treatment of SARS-CoV-2 infection during this COVID-19 pandemic. Several drugs have been identified which including remdesivir, two antimalarials (chloroquine and hydroxychloroquine) and immunosuppressive agents. The effects of most drug interventions are currently highly uncertain and several drugs and vaccines are under trail for the effective treatment of COVID-19 virus, until an effective treatment will discover social distancing and physical hygiene should be practiced strictly.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33373324</PMID>
<DateCompleted><Year>2021</Year>
<Month>05</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>05</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1078-6791</ISSN>
<JournalIssue CitedMedium="Print"><Volume>27</Volume>
<Issue>S1</Issue>
<PubDate><Year>2021</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Alternative therapies in health and medicine</Title>
<ISOAbbreviation>Altern Ther Health Med</ISOAbbreviation>
</Journal>
<ArticleTitle>The Potentially Recommended Pharmacotherapy for COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>24-28</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">AT6554</ELocationID>
<Abstract><AbstractText Label="Context" NlmCategory="UNASSIGNED">A completely unique coronavirus (2019-nCoV), formally referred to as severe acute respiratory syndrome (SARS-CoV-2), appeared in China. SARS-CoV-2 is an etiological mediator of coronavirus 2 (COVID-19), characterized by pneumonic contagion in human beings. In spite of forceful suppression, this virus has spread worldwide. No specific drugs have been approved by the FDA for treating COVID-19 patients.</AbstractText>
<AbstractText Label="Objective" NlmCategory="UNASSIGNED">The study intended to examine the data from studies on clinical management of COVID-19.</AbstractText>
<AbstractText Label="Design" NlmCategory="UNASSIGNED">The research team performed a literature review, searching relevant literature databases. The sources of data included bioRxiv, medRxiv, Google Scholar, Embase, PsychINFO, WanFang Data, and PubMed. The search terms were treatment of the novel coronavirus, management of nCoV-19, chloroquine, and hydroxychloroquine.</AbstractText>
<AbstractText Label="Setting" NlmCategory="UNASSIGNED">The study took place in the main library of the University of Sargodha in Sargodha, Pakistan.</AbstractText>
<AbstractText Label="Results" NlmCategory="UNASSIGNED">The study identified 42 unique studies that had reported and confirmed over 1500 cases of nCoV-19 by April 21, 2020. The studies found that clinical management, for patients who presented with symptoms, included supportive care and control measures that comprised mechanical ventilator support and supplementary oxygen.</AbstractText>
<AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">There have been intensive attempts to explore drug therapy for the prophylaxis and treatment of SARS-CoV-2 infection during this COVID-19 pandemic. Several drugs have been identified which including remdesivir, two antimalarials (chloroquine and hydroxychloroquine) and immunosuppressive agents. The effects of most drug interventions are currently highly uncertain and several drugs and vaccines are under trail for the effective treatment of COVID-19 virus, until an effective treatment will discover social distancing and physical hygiene should be practiced strictly.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nazir</LastName>
<ForeName>Saeed Ur Rashid</ForeName>
<Initials>SUR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nazir</LastName>
<ForeName>Taha</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sultana</LastName>
<ForeName>Misbah</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Shamim</LastName>
<ForeName>Rahat</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Riaz</LastName>
<ForeName>Humayun</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sultana Munir</LastName>
<ForeName>Safia</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kayani</LastName>
<ForeName>Ruqaiya Rasheed</ForeName>
<Initials>RR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Manzoor</LastName>
<ForeName>Saba</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Islam</LastName>
<ForeName>Azharul</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Altern Ther Health Med</MedlineTA>
<NlmUniqueID>9502013</NlmUniqueID>
<ISSNLinking>1078-6791</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010154" MajorTopicYN="N" Type="Geographic">Pakistan</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>12</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>12</Month>
<Day>29</Day>
<Hour>17</Hour>
<Minute>8</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33373324</ArticleId>
<ArticleId IdType="pii">AT6554</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Islam, Azharul" sort="Islam, Azharul" uniqKey="Islam A" first="Azharul" last="Islam">Azharul Islam</name>
<name sortKey="Kayani, Ruqaiya Rasheed" sort="Kayani, Ruqaiya Rasheed" uniqKey="Kayani R" first="Ruqaiya Rasheed" last="Kayani">Ruqaiya Rasheed Kayani</name>
<name sortKey="Manzoor, Saba" sort="Manzoor, Saba" uniqKey="Manzoor S" first="Saba" last="Manzoor">Saba Manzoor</name>
<name sortKey="Nazir, Saeed Ur Rashid" sort="Nazir, Saeed Ur Rashid" uniqKey="Nazir S" first="Saeed Ur Rashid" last="Nazir">Saeed Ur Rashid Nazir</name>
<name sortKey="Nazir, Taha" sort="Nazir, Taha" uniqKey="Nazir T" first="Taha" last="Nazir">Taha Nazir</name>
<name sortKey="Riaz, Humayun" sort="Riaz, Humayun" uniqKey="Riaz H" first="Humayun" last="Riaz">Humayun Riaz</name>
<name sortKey="Shamim, Rahat" sort="Shamim, Rahat" uniqKey="Shamim R" first="Rahat" last="Shamim">Rahat Shamim</name>
<name sortKey="Sultana Munir, Safia" sort="Sultana Munir, Safia" uniqKey="Sultana Munir S" first="Safia" last="Sultana Munir">Safia Sultana Munir</name>
<name sortKey="Sultana, Misbah" sort="Sultana, Misbah" uniqKey="Sultana M" first="Misbah" last="Sultana">Misbah Sultana</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000102 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000102 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33373324
   |texte=   The Potentially Recommended Pharmacotherapy for COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33373324" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

The Potentially Recommended Pharmacotherapy for COVID-19.

The Potentially Recommended Pharmacotherapy for COVID-19.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki